Researchers from the exploratory mRNA COVID- 19 shot manufacturer Moderna published a paper stating that the technology used in gene therapy carries toxicity risks. On January 23, Nature Reviews Drug Discovery published a paper with the title” Strategies to reduce the risks of transcriptional drug and vaccine toxicity.” The rapid development and administration of billions of coronavirus disease 2019 ( COVID- 19 ) vaccine doses worldwide has been made possible by the “mRNA formulated with fatty nanoparticles” revolutionary technology. But, the paper read that it is difficult to prevent undesirable toxicity with mRNA drugs and vaccines. There are toxicity issues with fat nanoparticle structural components, production techniques, administration routes, and proteins made from alloyed mRNAs. Here, we talk about these issues, particularly how mRNA and lipid nanoparticle toxicity can be caused by cell tropism and tissue distribution, as well as their potential reactogenicity. The researchers continued,” We concentrate on negative outcomes from mRNA applications for protein replacement and gene editing therapies as well as vaccines, tracing common metabolic and mobile pathways.” On February 7, 2024, Moderna Scientists WarnmRNA Vaccines Carry Toxicity Risks https ://t.co/kv5SB9V6Ct—zerohedge ( @zerostedge) Moderna did n’t respond to a request for comment. According to researchers with Moderna, the technology used in the COVID-19 vaccine carries toxicity risks.
How to effectively de-risk possible toxicities associated with mRNA is currently a significant challenge. The Epoch Times reports that Dr. Kat Lindley ( @KLVeritas ) and Eric Jacquinet, Dimitrios Bitounis, and Maximillian Rogers, who were employed by Moderna at the time the paper was written, are among its authors. In response to a request for comment, Moderna did n’t respond. The mRNA vaccines have a number of well-known side effects, such as severe allergic shock and heart inflammation. These may result from hypersensitivity reactions, which can be induced by “any LNP- mRNA component,” but which, according to the scientists, are most likely triggered by PEGlyated lipid nanoparticles because they are” the most likely reactogenic component.” An ingredient in the Pfizer and Moderna COVID- 19 vaccines called polyethylene glycol, or PEG, is known to trigger allergic reactions. While Pfizer has proposed that the LNPs are to blame for the problem, outdoor scientists disagree on the mechanism underlying heart inflammation.
The fresh paper drew information from earlier works and other sources. No novel experiments were conducted by the authors. Despite health officials ‘ claims that when the vaccines were released, such materials would leave the body within days, some of the papers cited found mRNA and the spike protein delivered by Moderna’s vaccine in various animal parts weeks or months after vaccination. Moderna has a large number of transcriptional products in its pipeline despite the toxicity risks and well-known side effects of the technology. The biotechnology business just started running tests in the UK for an transcriptional cancer vaccine. Trials for a novel mRNA “vaccine” are starting in moderna. [[{“value”:”
Scientists from Moderna, a maker of experimental mRNA shots COVID-19, published a paper stating that the technology used for gene therapy poses toxicity risks. Nature Reviews Drug Discovery published the paper titled “Strategies for reducing the risks of mRNA vaccine and drug toxicity” on January 23rd. “mRNA formulated using lipid nanoparticles has been a transformative technique that has enabled rapid development and administration to billions of doses of COVID-19 vaccines worldwide. The paper stated that mRNA vaccines and drugs present challenges in avoiding unacceptable toxicities. “Lipid Nanoparticle structural components and production methods, route administration, and proteins produced from complexed-mRNAs are all toxicity concerns.” We discuss these concerns here, focusing on how cell tropism, tissue distribution, and mRNA nanoparticles’ possible reactogenicity can lead to toxicity. The scientists said that they would focus on adverse reactions from mRNA applications in gene editing and protein replacement therapies, as well as vaccines. They would trace common biochemical and cell pathways. Moderna Scientists Warn mRNA Vaccines Carry Toxicity Risks https://t.co/kv5SB9V6Ct — zerohedge (@zerohedge) February 7, 2024 Moderna didn’t respond to a request for comment. Scientists with Moderna said that the COVID-19 vaccine’s technology carries toxicity risk.”A major challenge now is how to efficiently de-risk potential toxicities associated with mRNA… pic.twitter.com/9djj6SNjQ7 — Dr. Kat Lindley (@KLVeritas) February 5, 2024 The Epoch Times reports: Authors of the paper include Moderna employees Eric Jacquinet and Dimitrios Bitounis and Maximillian Rogers, who was working at Moderna when the paper was being done. Moderna did not respond to a comment request. The mRNA vaccinations have a number of known side effects including heart inflammation and severe allergy shock. Scientists believe that hypersensitivity reactions can be triggered by “any LNP mRNA component”, but most likely by PEGlyated Lipid Nanoparticles. They say this is the “most potentially reactogenic component.” PEG, a component in the Pfizer COVID-19 vaccines and Moderna COVID-19, is known to cause allergies. Scientists outside the company are divided on the cause of the heart inflammation. Pfizer, however, believes that LNPs may be the culprit.
The new paper was based on previous publications and other data. The authors did not perform any new experiments. Some of the papers cited include those that found mRNA or the spike protein delivered by Moderna’s vaccine in different parts of humans weeks or months after vaccination. Health officials claimed when the vaccines rolled out, that such materials would leave the body within a few days. Moderna has dozens mRNA products on its pipeline despite the known side effects and toxicity risks of mRNA technology. The biotechnology firm recently began trials for an mRNA vaccine against cancer in the United Kingdom. Moderna Begins Trial For New mRNA ‘Vaccine’
“}]]
